Motivational Evaluation and Intervention With Co-Adapt Application for Healthy Ageing
NCT ID: NCT05116553
Last Updated: 2022-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
74 participants
INTERVENTIONAL
2021-11-11
2022-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Adherence Healthy Lifestyle With a Smartphone Application Based on Adults With Intellectual Disabilities
NCT01915381
Ageing as a Mindset: A Counterclockwise Experiment to Rejuvenate Older Adults
NCT03552042
Promoting Mental and Cognitive Health in Old Age Through Scalable Evidence-based Interventions
NCT07072338
Group Acceptance and Commitment Training (ACT) With Healthy Older Adults
NCT03839329
A Resilience Building Intervention to Promote Successful Aging
NCT03294655
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For this purpose, the use of an APP with a CA (Conversational Agent) will be implemented as a support to help people to identify one's thoughts and emotional states as well as increase their awareness about themselves.
Test will be administered at the beginning (T1) and at the end of the meetings (T2).
Participants will be randomly divided into one of two groups to understand whether APP and CA has a significant impact in increasing motivation and awareness of the need for a pathway with a professional.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Participants will be randomly divided into two group: the experimental group will receive the standard 2 Self Determination Theory (SDT) psychological interviews with the support of the APP with the Conversational Agent (CA), while the control group will receive the 2 SDT (Self Determination Theory) psychological interviews.
At the end of the pathway post-intervention test (T2) will be administered to the participants with the same questionnaire of the beginning.
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SDT (MI)
This group will receive standard 2 SDT (Self Determination Theory) psychological interviews.
SDT
Standard 2 SDT (Self Determination Theory) psychological interviews.
SDT (MI) + CA
This group will receive standard 2 SDT (Self Determination Theory) psychological interviews; moreover they will use an APP with a CA (Conversational Agent), an Artificial Intelligence.
SDT
Standard 2 SDT (Self Determination Theory) psychological interviews.
APP + CA
An APP with a CA (Conversational Agent).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SDT
Standard 2 SDT (Self Determination Theory) psychological interviews.
APP + CA
An APP with a CA (Conversational Agent).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a sufficient level of education to understand study procedures and be able to communicate with site personnel
* 50 to 70 years old
Exclusion Criteria
50 Years
67 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Idego srl
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tommaso Ciulli
Role: PRINCIPAL_INVESTIGATOR
Idego srl
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Idego srl
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COADAPT 2021 T-6.4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.